Skip to main content

Clinical trials

  • PROTECT IV

    The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart…

    Investigator
    R. David Anderson
    Ages
    18 Years - 90 Years
    Sexes
    All